Glucose-Insulin-Potassium Reduces the Incidence of Low Cardiac Output Episodes After Aortic Valve Replacement for Aortic Stenosis in Patients With Left Ventricular Hypertrophy
Author(s) -
Neil Howell,
Houman Ashrafian,
Nigel E Drury,
Aaron Ranasinghe,
Hussain Contractor,
Henrik Isackson,
Melanie Calvert,
Lynne Williams,
Nick Freemantle,
David W. Quinn,
David Green,
Michael Frenneaux,
Robert S. Bonser,
Jorge Mascaro,
Timothy R. Graham,
Stephen J. Rooney,
Ian C. Wilson,
Duilio Pagano
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.110.945170
Subject(s) - medicine , aortic valve replacement , cardiology , left ventricular hypertrophy , aortic valve , aortic valve stenosis , odds ratio , stenosis , blood pressure
Patients undergoing aortic valve replacement for critical aortic stenosis often have significant left ventricular hypertrophy. Left ventricular hypertrophy has been identified as an independent predictor of poor outcome after aortic valve replacement as a result of a combination of maladaptive myocardial changes and inadequate myocardial protection at the time of surgery. Glucose-insulin-potassium (GIK) is a potentially useful adjunct to myocardial protection. This study was designed to evaluate the effects of GIK infusion in patients undergoing aortic valve replacement surgery.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom